Lyell Immunopharma Inc. is a leading biotechnology company that develops innovative cell therapy solutions for cancer treatment. With a focus on harnessing the power of the immune system, Lyell aims to revolutionize cancer care by providing personalized and targeted therapies that offer improved efficacy and reduced side effects.
